Siwang Yu
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
- Biochemistry top 1%
- Phytochemicals and Antioxidant Activities
Papers in
- Pharmacology 15
- Pharmacological Effects of Natural Compounds 13
-
- Genomics, phytochemicals, and oxidative stress 33
- Glutathione Transferases and Polymorphisms 12
- Natural product bioactivities and synthesis 6
- Epigenetics and DNA Methylation 6
- Co-authors
- Ah‐Ng Tony Kong (25 shared papers)Tin Oo Khor (16 shared papers)Wenge Li (6 shared papers)Guoxiang Shen (7 shared papers)Changjiang Xu (5 shared papers)Jung Hwan Kim (5 shared papers)Woo‐Sik Jeong (1 shared paper)Xiaoling Yuan (4 shared papers)
- Journals
- Cancer Research (4 papers)The AAPS Journal (4 papers)Fitoterapia (4 papers)Toxicology and Applied Pharmacology (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Siwang Yu
93 papers receiving 5.3k citations
Siwang Yu's Hit Papers
Peers
Comparison fields: 5 of 135
- Pharmacology 545
- Biochemistry 339
- Molecular Biology 3.4k
- Molecular Medicine 209
- Biological Psychiatry 78
Countries citing papers authored by Siwang Yu
This map shows the geographic impact of Siwang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwang Yu more than expected).
Fields of papers citing papers by Siwang Yu
This network shows the impact of papers produced by Siwang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwang Yu. The network helps show where Siwang Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Siwang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 669 | |
| 2 | 2008 | 272 | |
| 3 | 2006 | 271 | |
| 4 | 2006 | 243 | |
| 5 | 2016 | 225 | |
| 6 | 2015 | 221 | |
| 7 | 2010 | 198 | |
| 8 | 2007 | 182 | |
| 9 | 2008 | 169 | |
| 10 | Hydrogen sulfide alleviates particulate matter-induced emphysema and airway inflammation by suppressing ferroptosis Hit paper breakdown → | 2022 | 149 |
| 11 | 2006 | 136 | |
| 12 | 2007 | 134 | |
| 13 | 2007 | 125 | |
| 14 | 2006 | 119 | |
| 15 | 2008 | 116 | |
| 16 | 2015 | 102 | |
| 17 | 2012 | 100 | |
| 18 | 2002 | 93 | |
| 19 | 2013 | 81 | |
| 20 | 2018 | 77 |
About Siwang Yu
Siwang Yu is a scholar working on Pharmacology, Molecular Biology, Pharmacology, Oncology and Biotechnology, having authored 95 papers that have together received 5.4k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (33 papers), Pharmacological Effects of Natural Compounds (13 papers), Glutathione Transferases and Polymorphisms (12 papers), Adipose Tissue and Metabolism (7 papers), Natural product bioactivities and synthesis (6 papers), Epigenetics and DNA Methylation (6 papers), Air Quality and Health Impacts (4 papers) and Marine Sponges and Natural Products (4 papers). The work is most often cited by research in Pharmacology (545 citations), Biochemistry (339 citations), Molecular Biology (3.4k citations), Molecular Medicine (209 citations) and Biological Psychiatry (78 citations). Siwang Yu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Ah‐Ng Tony Kong, Tin Oo Khor, Wenge Li, Guoxiang Shen, Changjiang Xu, Jung Hwan Kim, Woo‐Sik Jeong, Xiaoling Yuan, Xue Qiao and Angela Kong. Their work appears in journals such as Cancer Research, The AAPS Journal, Fitoterapia, Toxicology and Applied Pharmacology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.